XBiotech Inc.
XBIT
$2.42
-$0.02-0.82%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | 49.42% | -155.92% | -19.80% | 86.50% | -8.82% |
| Total Depreciation and Amortization | -24.89% | -13.90% | -2.73% | 0.92% | 2.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -57.18% | -121.21% | 458.48% | -418.76% | 55.12% |
| Change in Net Operating Assets | -853.32% | 480.73% | 110.36% | -748.09% | 67.16% |
| Cash from Operations | -33.47% | -250.95% | 27.13% | 47.35% | 6.69% |
| Capital Expenditure | -- | 59.52% | 67.46% | 91.87% | 63.14% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 109.57% | 59.52% | 67.46% | 91.87% | 63.14% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -100.00% | -100.00% | -100.00% | -201.94% |
| Foreign Exchange rate Adjustments | -498.59% | 128.54% | -270.01% | 656.14% | 117.95% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 39.86% | -108.95% | -2.94% | 76.35% | -1,751.57% |